UBE2J1 is the E2 ubiquitin-conjugating enzyme regulating androgen receptor degradation and antiandrogen resistance
Carla R. Tirado(Southwestern Medical Center), Ping Mu(Yale Cancer Center)
Cited by 17
Related Papers
Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer
|Cancer Cell|2020|252
Ectopic JAK–STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance
|Nature Cancer|2022|148
Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer
|Cancer Cell|2023|47
RUNX1T1-HDAC Reprogramming of the HOX Code Signaling Drives a Targetable Pan-Cancer Lineage Plasticity
|bioRxiv (Cold Spring Harbor Laboratory)|2025|1